Research Analysts Offer Predictions for Celsius Holdings, Inc.’s Q2 2024 Earnings (NASDAQ:CELH)

Celsius Holdings, Inc. (NASDAQ:CELH) – Stock analysts at Roth Capital cut their Q2 2024 earnings per share estimates for shares of Celsius in a research report issued to clients and investors on Wednesday, May 8th. Roth Capital analyst S. Mcgowan now expects that the company will post earnings of $0.24 per share for the quarter, down from their previous estimate of $0.27. The consensus estimate for Celsius’ current full-year earnings is $1.09 per share. Roth Capital also issued estimates for Celsius’ Q3 2024 earnings at $0.29 EPS, Q1 2025 earnings at $0.27 EPS, Q2 2025 earnings at $0.35 EPS, Q3 2025 earnings at $0.42 EPS, Q4 2025 earnings at $0.37 EPS and FY2025 earnings at $1.41 EPS.

Celsius (NASDAQ:CELH) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.07. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The business had revenue of $355.70 million during the quarter, compared to analyst estimates of $390.37 million. During the same quarter last year, the business posted $0.13 earnings per share. Celsius’s revenue for the quarter was up 36.9% compared to the same quarter last year.

A number of other analysts have also commented on the company. Roth Mkm lifted their price objective on Celsius from $90.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, March 14th. Piper Sandler increased their price objective on shares of Celsius from $76.00 to $90.00 and gave the company an “overweight” rating in a report on Friday, March 1st. Wedbush reaffirmed an “outperform” rating and issued a $100.00 price objective on shares of Celsius in a research note on Friday, May 3rd. UBS Group dropped their target price on shares of Celsius from $99.00 to $92.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, Maxim Group raised their price target on Celsius from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $84.95.

Celsius Stock Performance

NASDAQ CELH opened at $77.13 on Thursday. Celsius has a 52 week low of $34.74 and a 52 week high of $99.62. The stock has a market capitalization of $17.82 billion, a P/E ratio of 100.17, a price-to-earnings-growth ratio of 2.22 and a beta of 1.93. The stock has a fifty day moving average of $81.42 and a 200-day moving average of $65.97.

Institutional Trading of Celsius

Institutional investors and hedge funds have recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC lifted its position in Celsius by 1,350.0% in the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company’s stock valued at $25,000 after acquiring an additional 135 shares in the last quarter. Heritage Wealth Advisors bought a new stake in Celsius in the 3rd quarter worth about $32,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Celsius during the 3rd quarter valued at about $36,000. FinTrust Capital Advisors LLC bought a new position in Celsius during the first quarter valued at approximately $25,000. Finally, Signaturefd LLC lifted its holdings in shares of Celsius by 212.0% during the 3rd quarter. Signaturefd LLC now owns 337 shares of the company’s stock valued at $58,000 after buying an additional 229 shares during the period. 60.95% of the stock is currently owned by institutional investors.

Insider Transactions at Celsius

In related news, major shareholder William H. Milmoe sold 428,568 shares of the company’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $59.67, for a total transaction of $25,572,652.56. Following the completion of the sale, the insider now directly owns 25,464,453 shares in the company, valued at approximately $1,519,463,910.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Celsius news, Director Caroline S. Levy sold 20,000 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the sale, the director now owns 37,891 shares in the company, valued at $3,590,930.07. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder William H. Milmoe sold 428,568 shares of the firm’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $59.67, for a total value of $25,572,652.56. Following the transaction, the insider now owns 25,464,453 shares of the company’s stock, valued at $1,519,463,910.51. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,043,363 shares of company stock worth $131,361,140. Insiders own 2.20% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.